Inventor · disambiguated record
Robert E. Klem
Also filed as: KLEM ROBERT · KLEM ROBERT E · KLEM ROBERT EARL
10 granted patents·7 pending applications·195 citations·filing 1974–2016
90Inventor score
Top patents by PatentIndex Score
17 records- 0188US5424440AFluorescent benzothiazole derivativesJBL SCIENT INC·Filed 1993·Granted Jun 13, 1995·51 cites·12 claims
- 0286US7119217B2Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing themGENTA INC·Filed 2003·Granted Oct 10, 2006·20 cites·58 claims
- 0386US7060690B2Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereofGENTA INC·Filed 2002·Granted Jun 13, 2006·17 cites·48 claims
- 0482US4799964APreparation of filler compositions for paperGRAIN PROCESSING CORP·Filed 1987·Granted Jan 24, 1989·48 cites·7 claims
- 0577US4066673AProcess for making quaternary amines of epichlorohydrinWESTVACO CORP·Filed 1974·Granted Jan 3, 1978·10 cites·2 claims
- 0667US5723599AOrganic polymer reagents for solid phase synthesis of oligonucleotidesGENTA INC·Filed 1995·Granted Mar 3, 1998·22 cites·21 claims
- 0761US7960364B2Methods for modulating the efficacy of nucleic acid based therapiesELEOS INC·Filed 2009·Granted Jun 14, 2011·0 cites·16 claims
- 0857US7795232B1Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersGENTA INC·Filed 2000·Granted Sep 14, 2010·1 cites·14 claims
- 0957US5811538AProcess for the purification of oligomersGENTA INC·Filed 1994·Granted Sep 22, 1998·20 cites·31 claims
- 1057US2008167263A1Methods for Modulating the Efficacy of Nucleic Acid Based TherapiesREARDAN DAYTON T·Filed 2007·Application pending·0 cites
- 1154US2009246781A1Method for early determination of recurrence after therapy for prostate cancerKLEM ROBERT·Filed 2009·Application pending·0 cites
- 1253US2013224752A1Method for early determination of recurrence after therapy for prostate cancerKLEM ROBERT·Filed 2013·Application pending·0 cites
- 1347US5726300AProcess for the synthesis of oligonucleotides and analogs with low water oxidation stepGENTA INC·Filed 1994·Granted Mar 10, 1998·6 cites·28 claims
- 1445US2013323739A1Method for determining recurrence or stable disease after treatment for prostate cancerKLEM ROBERT E·Filed 2013·Application pending·0 cites
- 1540US2017234874A1Integrated visual morphology and cell protein expression using resonance-light scatteringCLEARBRIDGE BIOPHOTONICS PTE LTD·Filed 2016·Application pending·0 cites
- 1637US2012329713A1Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomyKLEM ROBERT E·Filed 2012·Application pending·0 cites
- 1737US2010216867A1Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomersGENTA INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert E. Klem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →